SUBSCRIBE
SUBSCRIBE

Oregon

PRESS RELEASES
Press Releases
Sparrow Pharmaceuticals to Present Two Abstracts at ACR Convergence 2024 and Expand Phase 2 Clinical Trial of Clofutriben with Prednisolone for Polymyalgia Rheumatica to Fifth Cohort
November 14, 2024
 · 
2 min read
Press Releases
Sparrow Pharmaceuticals Announces Completion of Phase 2 Trial and FDA Orphan Drug Designation of Clofutriben for Endogenous Cushing’s Syndrome
October 28, 2024
 · 
3 min read
Press Releases
Thermo Fisher Scientific Expands Oral Solid Dose Development and Manufacturing Capabilities Across North America
September 27, 2024
 · 
3 min read
Press Releases
Sparrow Pharmaceuticals Presented New Data on Clofutriben and Prednisolone for Polymyalgia Rheumatica Treatment at DGRh Kongress 2024
September 19, 2024
 · 
2 min read
Press Releases
Serán Bioscience Announces $200 Million Strategic Growth Transaction and Plans for New Commercial Facility
September 17, 2024
 · 
5 min read
News
Compassion Center and SIDHE Research Institute Take the Lead in Ethical Hallucinogen Research to Revolutionize Mental Health Treatment
September 11, 2024
 · 
9 min read
News
Quantek Systems and Varian, a Siemens Healthineers Company, Announce Strategic Collaboration to Enhance Clinical Interoperability
July 16, 2024
 · 
2 min read
Drug Development
Sparrow Pharmaceuticals Presents Data from Ongoing Phase 2 Trial of Clofutriben (SPI-62) and Prednisolone as a Treatment for Polymyalgia Rheumatica at EULAR 2024
June 15, 2024
 · 
2 min read
Drug Development
Sparrow Pharmaceuticals to Present on HSD-1 Inhibitor Clofutriben (SPI-62) for Polymyalgia Rheumatica at the European Congress of Rheumatology 2024
June 6, 2024
 · 
1 min read
Drug Development
Ankyra Therapeutics Announces Trial in Progress Poster Presentation at 2024 ASCO Meeting and Approval of ANK-101 Phase 1 Protocol Amendment
June 1, 2024
 · 
4 min read
BioForest
Sparrow Pharmaceuticals’ David Katz, PhD, to Receive Outstanding Innovation Award at the 2024 Annual Endocrine Society Conference
May 30, 2024
 · 
2 min read
BioForest
Molecular You Announces Breakthrough in Early Detection of Pancreatic Cancer
April 22, 2024
 · 
3 min read
BioForest
Bruker Advances CCS-Enabled 4D-Proteomics timsTOF Solutions for Immunopeptidomes and Glycoproteomics at US HUPO
March 11, 2024
 · 
6 min read
Business
EndoSound™ Inc., Appoints Medical Device Commercial Leader Scott Aldrich Jr as Chief Executive Officer
February 29, 2024
 · 
2 min read
BioForest
Phylos® and People Science® Announce Results of IRB-Backed Controlled Research Study on the Energizing Effects of THCV
February 27, 2024
 · 
4 min read
BioForest
Study of First Affordable and Rapid Test for Beta Thalassemia Performs at 99% Accuracy in Diagnosing the Blood Disorder
February 5, 2024
 · 
1 min read
BioForest
EndoSound® Receives 510(k) Clearance for Breakthrough EVS® Innovation, a novel Endoscopic Ultrasound (EUS) technology
January 2, 2024
 · 
2 min read
Drug Development
Cascade Announces Poster Presentation at Society for Immunotherapy of Cancer (SITC) Annual Meeting
October 24, 2023
 · 
2 min read
Drug Development
Sparrow Pharmaceuticals Doses First Patient in Phase 2 ACSpire Study of SPI-62 for Autonomous Cortisol Secretion
October 24, 2023
 · 
3 min read
Covalon Presents Innovative Solutions Used in Top Hospitals at the Association for Vascular Access (AVA) Annual Scientific Meeting in Portland, OR
October 13, 2023
 · 
5 min read
Load More